Perhaps in addressing G6PD deficiency, the most promising in the horizon lies in drug development designed to correct the structural defects caused by the various genetic mutations that are becoming increasingly clearer (94)
As an analog of endogenous amylin, it is studied for its receptor-mediated signaling dynamics, sustained activation profile, and downstream neuroendocrine cascades within controlled laboratory environments
OTC medications were reported as #1, accounting for 16.5% of all exposures, and human prescription medications as #3
PTD-DBM : Encourages new growth and may reverse follicle miniaturization
Uncommon side effects of these medications can include pancreatitis, gastroparesis, bowel obstruction, gallstone attacks and bile duct blockages